New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies

Autori: Abbatecola AM, Maggi S, Paolisso G.

Data: 2008

Ambito di interesse: farmacologia, invecchiamento

Rivista: Drugs Aging

Potrebbero interessarti anche:

Rivista 3,52

MicroRNAs modulation and clinical outcomes at 1 year of follow-up in obese patients with pre-diabetes treated with metformin vs. placebo.

Autori: Sardu C, Trotta MC, Pieretti G, Gatta G, Ferraro G, Nicoletti GF, D' Onofrio N, Balestrieri ML, D' Amico M, Abbatecola A, Ferraraccio F, Panarese I, Paolisso G, Marfella R.

Data: 2021

Ambito di interesse: diabete

Rivista: Acta Diabetol.

Leggi dettagli

Rivista 12.56

Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective.

Autori: Fisicaro F, Di Napoli M, Liberto A, Fanella M, Di Stasio F, Pennisi M, Bella R, Lanza G, Mansueto G.

Data: 2021

Ambito di interesse: COVID-19 e sequele neurologiche

Rivista: Int J Environ Res Public Health. 2021 Feb 3;18(4):1415

Leggi dettagli

Rivista 18.15

Reconsidering the role of selective sodium channel blockers in genetic generalized epilepsy.

Autori: Cerulli Irelli E, Morano A, Fanella M, Orlando B, Salamone EM, Giallonardo AT, Di Bonaventura C.

Data: 2021

Ambito di interesse: Epilessia

Rivista: Acta Neurol Scand. 2021 Dec;144(6):647-654

Leggi dettagli

New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies

Potrebbero interessarti anche:

MicroRNAs modulation and clinical outcomes at 1 year of follow-up in obese patients with pre-diabetes treated with metformin vs. placebo.

Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective.

Reconsidering the role of selective sodium channel blockers in genetic generalized epilepsy.

Cosa fare per